- Home
- CRMD vs PCN Comparison
CRMD vs PCN Comparison
Compare CRMD & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | PCN |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 958.1M | 916.0M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | PCN |
|---|---|---|
| Price | $7.77 | $12.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 218.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.73% |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $214,303,672.00 | N/A |
| Revenue This Year | $629.55 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | $3.45 | ★ N/A |
| Revenue Growth | ★ 1647.67 | N/A |
| 52 Week Low | $5.60 | $10.70 |
| 52 Week High | $17.43 | $14.48 |
Technical Indicators
Market Signals| Indicator | CRMD | PCN |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 54.55 |
| Support Level | $7.15 | $12.72 |
| Resistance Level | $7.59 | $12.83 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 75.94 | 50.00 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About PCN Pimco Corporate & Income Strategy Fund
PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.